Barrett's esophagus in three children after antileukemia chemotherapy
- 15 December 1987
- Vol. 60 (12) , 2896-2900
- https://doi.org/10.1002/1097-0142(19871215)60:12<2896::aid-cncr2820601208>3.0.co;2-p
Abstract
Barrett's esophagus, a columnar metaplasia of the lower esophagus that is usually associated with gastroesophageal reflux (GER), was found in three children on long-term antileukemia chemotherapy. Two of the children had been on a standard acute lymphoblastic leukemia (ALL) maintenance protocol with 2 to 3 years of methotrexate and 6-mercaptopurine administration. The third child received daunorubicin, cytosine arabinoside, and 6-thioguanine for treatment of acute myelogenous leukemia (AML). None of the patients had clinical or pathologic evidence of GER disease. We propose that the Barrett's esophagus in these patie0ts did not result from the usual peptic esophagitis, but rather from chemotherapy-induced esophageal mucosal injury.This publication has 25 references indexed in Scilit:
- Barrett's EsophagusNew England Journal of Medicine, 1986
- Barrett's esophagus in childhoodGastroenterology, 1985
- Dysplasia in Barrett's esophagusZeitschrift für Krebsforschung und Klinische Onkologie, 1985
- The spectrum of carcinoma arising in Barrettʼs esophagusThe American Journal of Surgical Pathology, 1984
- The Pharmacology and Clinical Use of MethotrexateNew England Journal of Medicine, 1983
- Barrett's metaplasia and adenocarcinoma of the esophagus and gastroesophageal junctionHuman Pathology, 1982
- Barrett's EsophagusAnnals of Internal Medicine, 1982
- Adenocarcinoma Complicating Columnar Epithelium-lined (Barrett’s) EsophagusAmerican Journal of Clinical Pathology, 1978
- The Histologic Spectrum of Barrett's EsophagusNew England Journal of Medicine, 1976
- Oral Complications of Cancer ChemotherapyPostgraduate Medicine, 1975